Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.

  • AUT: Autism

    BPN: Behavioral Pharmacology and Neuroscience

    CBM: Clinical/Family/Behavioral Medicine

    CSS: Community, Social, and Sustainability Issues

    DDA: Developmental Disabilities

    DEV: Behavioral Development

    EAB: Experimental Analysis of Behavior

    EDC: Education

    OBM: Organizational Behavior Management

    PRA: Practice

    TBA: Teaching Behavior Analysis

    VRB: Verbal Behavior

12th Annual Autism Conference; Miami, FL; 2018

Event Details

Previous Page


Invited Paper Session #8

Funding ABA: The Intersection of Law and Applied Behavior Analysis in Evidence-Based Autism Treatment

Monday, February 5, 2018
4:00 PM–4:50 PM
Regency Ballroom
Area: AUT; Domain: Service Delivery
Instruction Level: Intermediate
CE Instructor: Julie Kornack, Ph.D.
Chair: Jonathan J. Tarbox (University of Southern California; FirstSteps for Kids)
JULIE KORNACK (Center for Autism and Related Disorders)
Julie Kornack is the director of public policy for the Center for Autism and Related Disorders. Her work includes identifying, developing, and supporting state and federal initiatives that increase access to autism treatment, as well as analyzing the impact of federal and state legislative and regulatory developments on access to autism treatment. She co-authored A Response to Papatola and Lustig’s Paper on Navigating a Managed Care Peer Review: Guidance for Clinicians using Applied Behavior Analysis in the Treatment of Individuals on the Autism Spectrum, recently published in Behavior Analysis in Practice, and is the author of The History, Pitfalls, and Promise of Licensure in the Field of Behavior Analysis, due to be published this fall. Her analysis of the economics of autism treatment was published in the Handbook of Early Intervention for Autism Spectrum Disorders: Research, Policy, and Practice, and she is an editor of Evidence-Based Treatment for Children with Autism: The CARD Model. She serves on the board of directors of the National Coalition for Access to Autism Services, as well as several state and national advisory committees and task forces.

With applied behavior analysis (ABA) joining the mainstream of medically necessary treatments, insurers and managed care organizations have moved to introduce policies intended to influence treatment decisions – critical decisions about how many hours of ABA are medically necessary, which locations are allowable, and who must participate in treatment. Arbitrary policies that constrain behavior analysts from designing and implementing the most effective treatment plan are often indicative of an overreach by the funding source. With no statutory definition of medical necessity governing commercial insurance, behavior analysts are in a position to shape funding practices by understanding the laws and regulations that underpin patient rights in the determination of medically necessary treatment. This presentation seeks to empower behavior analysts to challenge improper policies, stand by their clinical recommendations, and ensure that behavior analysts – not funding sources – set the standard of care for ABA.

Target Audience:

Board certified behavior analysts, licensed psychologists, graduate students.

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) discuss the variables that should contribute to determinations of medical necessity; (2) identify the difference between educational and medically necessary ABA; (3) recognize improper limitations and discriminatory practices of funding sources; (4) protect patient rights to medically necessary treatment; and (5) preserve and shape the standard of care in the field of ABA.



Back to Top
Modifed by Eddie Soh